Wendy Wade
Papers
1
Total Citations
18
H-Index
1
About
Dr. Wendy Wade is a leading clinical researcher in head and neck oncology, with a focused expertise in de-escalation strategies for human papillomavirus (HPV)-positive oropharyngeal cancer. Her major contribution is the design and leadership of the landmark PATHOS trial, a phase II/III study investigating risk-stratified, reduced intensity adjuvant treatment following transoral surgery. This work directly addresses the critical need to mitigate severe, long-term toxicities from standard therapies—such as dysphagia and fibrosis—while preserving the excellent survival rates characteristic of HPV-positive disease. By pioneering a personalized, de-escalated approach, Dr. Wade’s research has reshaped the therapeutic landscape, offering patients a higher quality of life without compromising oncologic outcomes. Her work has garnered significant attention, with the PATHOS protocol paper cited 18 times, reflecting its influence on clinical trial design. Dr. Wade’s contributions are vital for students and researchers interested in balancing treatment efficacy with survivorship, demonstrating how rigorous, risk-adapted trials can transform care for a rapidly growing patient population.
Research Focus
Key Achievements
Top Papers
- 1